11/19
01:22 pm
atnm
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $5.00 price target on the stock.
Low
Report
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $5.00 price target on the stock.
11/18
08:12 am
atnm
Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024 [Yahoo! Finance]
Medium
Report
Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024 [Yahoo! Finance]
11/18
08:00 am
atnm
Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024
Medium
Report
Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024
11/15
03:26 pm
atnm
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Low
Report
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
11/11
11:10 pm
atnm
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/4
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Shareholders With Losses Are Urged To Contact The Schall Law Firm
Low
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Shareholders With Losses Are Urged To Contact The Schall Law Firm
11/4
07:30 am
atnm
Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
Medium
Report
Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
11/3
11:00 am
atnm
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
Low
Report
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
11/2
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm
Low
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm
10/31
11:00 am
atnm
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
Medium
Report
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
10/30
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Violations Of Securities Laws And Affected Shareholders Should Contact The Schall Law Firm
Medium
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Violations Of Securities Laws And Affected Shareholders Should Contact The Schall Law Firm
10/29
11:00 am
atnm
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Actinium Pharmaceuticals Inc For Fraud
Low
Report
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Actinium Pharmaceuticals Inc For Fraud
10/28
11:00 am
atnm
The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
Low
Report
The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
10/27
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Medium
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
10/26
11:00 am
atnm
The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
Medium
Report
The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
10/25
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm
Low
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm
10/24
11:00 am
atnm
The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
Medium
Report
The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
10/23
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Low
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
10/22
11:00 am
atnm
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
Medium
Report
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
10/21
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Shareholders Are Urged To Reach Out To The Schall Law Firm
Low
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Shareholders Are Urged To Reach Out To The Schall Law Firm
10/20
11:00 am
atnm
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud
Medium
Report
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud
10/19
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Affected Shareholders Are Urged To Contact The Schall Law Firm
Medium
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Affected Shareholders Are Urged To Contact The Schall Law Firm
10/18
11:00 am
atnm
The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
Medium
Report
The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud
10/17
11:00 am
atnm
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Medium
Report
Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
10/16
11:00 am
atnm
The Schall Law Firm Encourages Investors To Take Part In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud
Medium
Report
The Schall Law Firm Encourages Investors To Take Part In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud